Low bone mineral density and fracture risk in HIV infection

2008 ◽  
Vol 3 (6) ◽  
pp. 523-526
Author(s):  
James CM Brust ◽  
Julia H Arnsten
2009 ◽  
Vol 200 (11) ◽  
pp. 1746-1754 ◽  
Author(s):  
Alexandra Calmy ◽  
Christoph A. Fux ◽  
Richard Norris ◽  
Nathalie Vallier ◽  
Cécile Delhumeau ◽  
...  

2018 ◽  
Vol 34 (2) ◽  
pp. 262-269 ◽  
Author(s):  
Pieter Evenepoel ◽  
Kathleen Claes ◽  
Bjorn Meijers ◽  
Michaël Laurent ◽  
Bert Bammens ◽  
...  

AIDS ◽  
2007 ◽  
Vol 21 (5) ◽  
pp. 617-623 ◽  
Author(s):  
Julia H Arnsten ◽  
Ruth Freeman ◽  
Andrea A Howard ◽  
Michelle Floris-Moore ◽  
Yungtai Lo ◽  
...  

2012 ◽  
Vol 18 (11) ◽  
pp. 1522-1528 ◽  
Author(s):  
Ruth Dobson ◽  
Sreeram Ramagopalan ◽  
Gavin Giovannoni

People with multiple sclerosis (MS) have many reasons to have low bone mineral density and an increased fracture risk. Osteoporosis is a major cause of morbidity and mortality, and is more common in people with MS than the general population. A number of studies have examined the relationship between multiple sclerosis and reduced bone mineral density. In this topical review we seek to address the risk of low bone mineral density, osteoporosis and fractures associated with MS, and make practical suggestions as to how this pertinent issue may be approached in clinical practice.


2013 ◽  
Vol 161 (8) ◽  
pp. 1910-1914 ◽  
Author(s):  
Eric W. Tan ◽  
Roosevelt U. Offoha ◽  
Gretchen L. Oswald ◽  
Richard L. Skolasky ◽  
Ashvin K. Dewan ◽  
...  

2021 ◽  
Vol 2021 ◽  
pp. 1-6
Author(s):  
Faryal Mirza ◽  
Sabina Zawadzka ◽  
Anne Abbate ◽  
Michael Thompson ◽  
Dorothy Wakefield ◽  
...  

People living with HIV are known to have greater risk of low bone mineral density than HIV-negative peers. The reasons for this disparity are multifactorial. To address this increased risk, the Infectious Diseases Society of America (IDSA) released fracture risk screening recommendations in 2015, which differ significantly from recommendations that apply to the general population. A study was conducted at the University of Connecticut to assess for provider awareness and adherence to these recommendations. Electronic surveys were sent to providers, and patients were also surveyed for risk factors and prevalence of low bone mineral density. The results of the provider survey showed low rates of awareness of the IDSA screening recommendations. A substantial proportion of patients surveyed met criteria for low BMD screening but did not have dual-energy X-ray absorptiometry (DXA) ordered by their provider. As an intervention, providers were sent information via e-mail regarding current screening recommendations, as well as notifications if their patient met criteria for DXA screening. A twelve-month follow-up survey showed increased provider knowledge of screening recommendations and improved screening practices. Additionally, the results of a logistic regression analysis of patient factors showed that increasing age and male sex were positively associated with fragility fracture risk. Increased duration of antiretroviral therapy use was associated with a lower likelihood of fragility fracture.


2007 ◽  
Vol 92 (12) ◽  
pp. 4522-4528 ◽  
Author(s):  
Mark J. Bolland ◽  
Andrew B. Grey ◽  
Greg D. Gamble ◽  
Ian R. Reid

Abstract Context: HIV infection has been associated with low bone mineral density (BMD) in many cross-sectional studies, although longitudinal studies have not demonstrated accelerated bone loss. The cross-sectional studies may have been confounded by the failure to control for low body weight in HIV-infected patients. Objective: Our objective was to determine whether low body weight might explain the association of HIV infection with low BMD. Data Sources: MEDLINE and EMBASE were searched for English language studies published from 1966 to March 2007, and conference abstracts prior to 2007 were hand-searched. Study Selection: All studies reporting BMD and weight or body mass index in adult patients with HIV and a healthy age- and sex-comparable control group were included. Nine of 40 identified studies and one of 68 identified abstracts were eligible. Data Synthesis: We adjusted for the between-groups weight differences using regression coefficients from published cohorts of healthy men and women. On average, HIV-infected patients were 5.1 kg [95% confidence interval (CI), −6.8, −3.4; P < 0.001] lighter than controls. At all skeletal sites, unadjusted BMD was lower by 4.4–7.0% in the HIV-infected groups than the controls (P < 0.01). After adjustment for body weight, residual between-groups differences in BMD were small (2.2–4.7%) [lumbar spine, −0.02 (95% CI, −0.05, 0.01) g/cm2; P = 0.12; total hip, −0.02 (95% CI, −0.04, 0.00) g/cm2; P = 0.031; femoral neck, −0.04 (95% CI, −0.07, −0.01) g/cm2; P = 0.013; and total body, −0.03 (95% CI, −0.07, 0.01) g/cm2, P = 0.11]. Conclusion: HIV-infected patients are lighter than controls and low body weight may largely account for the high prevalence of low BMD reported in HIV-infected patients. However, in the setting of current treatment practice, HIV infection per se is not a risk factor for low BMD.


Sign in / Sign up

Export Citation Format

Share Document